Skip to main content

Table 3 Results of the univariate and multivariate regression analyses for the predictors of the no-reflow phenomenon

From: New CHA2DS2-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

Variables

Unadjusted OR(95% CI)

P value

Adjusted OR(95% CI)

P value

LVEF

0.95(0.92–0.98)

0.002

0.98(0.94–1.03)

0.428

Age

1.03(1.01–1.06)

0.005

0.991(0.953–1.03)

0.664

CK-MB

1.004(1.002–1.007)

0.001

1.007(1.003–1.012)

0.002

eGFR

0.982(0.971–0.993)

0.001

0.98(0.97–1.003)

0.093

Killip class

1.86(1.08–3.21)

0.025

0.101(0.02–0.54)

0.007

Stent length

1.01(0.998–1.02)

0.10

1.03(1.01–1.05)

0.012

Stent diameter

0.86(0.504–1.47)

0.581

0.87(0.38–2.04)

0.755

Multivessel disease

1.007(0.61–1.67)

0.979

0.014(0.003–0.08)

< 0.001

Tirofiban infusion

1.53(0.94–2.51)

0.091

0.23(0.07–0.73)

0.012

CHA2DS2-VASc-HSF score

2.21(1.78–2.75)

< 0.001

31.31(12.53–78.26)

< 0.001

  1. Abbreviations: CK-MB creatine kinase-myocardial band, eGFR estimated glomerular filtration rate, OR odds ratio, LVEF left ventricular ejection fraction, CI confidence interval